Innovation: Planned vs. Accidental Posted January 6, 2016That the biggest pharmaceutical innovations have often been accidental isn’t a secret. Research has even shown that happy accidents or serendipity may be statistically significant. Generally, that’s good news for an R&D-driven sector like pharma. Still, it’s worth asking how to create the conditions for or increase the chances of getting lucky. A recent NY Times story suggests that being a “super-encounterer” of data and information may help make more happy accidents happen. The key point: the more and diverse the data sets innovators can review, the more likely they are to spot huge opportunities. The article outlines an emerging “science of serendipity”– or that there can and should be a process for achieving “eureka” moments of breakthrough innovations. In other words, pharmas need a repeatable process for identifying and prioritizing their serendipitous opportunities.